DOC at a glance
Healthpeak Properties (DOC, SEC CIK 765880) filed its latest 10-K annual report on February 3, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on August 4, 2026 and Form 4 insider filings as recently as June 2, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Healthpeak Properties (DOC) reported revenue of $604.0 million (up 6.2% from FY2024) and net income of $71.3 million. Diluted EPS was $0.10.
- As of June 30, 2026, 41 institutional investment managers tracked by SignalX reported holding Healthpeak Properties (DOC) shares worth $8.4 billion in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $604.0M
- +6.2% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 41 funds
- $8.4B · +1 vs prior quarter
- Latest 8-K
- Aug 4, 2026
- Item 7.01 · Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Risk Factors
- U.S. federal policy shifts (NIH funding cuts, drug pricing, tariffs) creating life science tenant funding uncertainty, risking rent payment and expansion
- Exposure to Medicare/Medicaid funding cuts and Affordable Care Act subsidy expiration impacting tenants in non-expansion states, affecting outpatient medical segment revenues
- Tariffs and supply chain disruptions raising construction costs and delaying development projects, increasing capital access risk
- Competition risk from international biotech sectors in China with favorable regulations diverting R&D investment away from U.S. lab tenants
- Tenant insolvency risk under U.S. Bankruptcy Code limiting lease remedies and delaying rent collections, especially under master leases across multiple properties
Management Discussion & Analysis
- Revenue from resident fees and services $568M in 2024, up $41M YoY from $527M
- Adjusted NOI $159.6M in 2024 vs $135.6M in 2023, +17.7% YoY, driven by higher fees and occupancy despite higher expenses
- Best segment: Merger-Combined Same-Store with 17.7% NOI growth; no explicit worst segment disclosed
- Operating cash flow $1.25B in 2025, up $181M YoY; investing outflows increased $921M; financing activities provided $136M vs $-941M prior year
- Capital allocation: $94M in common stock repurchases in 2025; dividends increased to $1.22/share annually; $168M development commitments, $9.8B total debt with recent issuances and repayments
- Forward outlook: Management expects sufficient liquidity for operations, debt service, distributions, and capital needs; notes risks from credit rating downgrades and market conditions impacting borrowing costs
Business Overview
- Core business model: Own, operate, develop high-quality U.S. healthcare real estate focused on outpatient medical, lab, and senior housing properties
- New segment emphasis: Preparation for Janus Living IPO, transferring 34 senior housing communities (10,422 units) into a publicly listed REIT structure under majority ownership
- Strategic shift: Following merger with Physicians Realty Trust, added 299 outpatient medical buildings, expanding scale and tenant base significantly
- Quantitative metric: Portfolio grew to 689 properties at 12/31/2025; senior housing includes 34 properties plus acquiring remaining 46.5% of SWF SH JV in Jan 2026
- Noteworthy fact: Senior housing segment redefined to combine life plan communities with sovereign wealth fund JV, reflecting new reportable segment structure for 2025
AI summary of the DOC 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Segment Adjusted NOI: outpatient medical $198.005M, lab $142.614M, senior housing $45.851M
- Best-performing segment outpatient medical with $206.587M NOI
- Janus Living offerings generated $1.685B gross proceeds, less $93M underwriting fees
- Capital deployment included $100M share repurchases and $399M seller-financing principal repayment
- Headwinds: elevated interest rates, higher construction costs, tariffs, capital constraints, and healthcare policy uncertainty
Risk Factors
- No risk-factors section provided; changes from the most recent 10-K cannot be assessed
- Share repurchase authorization: 2024 program expired July 2026
- New $500 million repurchase program approved July 30, 2026
- Liquidity allocation: $100 million spent repurchasing 5.95 million shares at $16.81 per share
AI summary of the DOC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Supplemental report covers Healthpeak’s three and six months ended June 30, 2026
- Exhibit 99.2 contains financial results and related investor information
Item 2.02: Results of Operations and Financial Condition
- Q2 and first-half 2026 results released for periods ended June 30, 2026
- Non-GAAP reconciliations accompany the release, requiring review alongside GAAP results
Item EX-99.1: Item EX-99.1
- Q2 revenue rose to $771.6M, while FFO as Adjusted held at $0.46 per share, signaling stable underlying earnings
- 2026 FFO guidance increased to $1.73-$1.77 per share, with same-store cash NOI guidance raised to 0%-1.5%
Item 2.02: Results of Operations and Financial Condition
- Q1 2026 results for quarter and three months ended March 31, 2026
- Press release furnished as Exhibit 99.1, containing the company’s reported financial results
Item 7.01: Regulation FD Disclosure
- Q1 2026 supplemental report furnished as Exhibit 99.2, covering results for three months ended March 31, 2026
- Investor materials available through Healthpeak’s Investor Relations website for detailed financial and operating metrics
Item EX-99.1: Item EX-99.1
- Q1 revenue rose 7% to $753.0M, while net income reached $0.28 per share versus $0.06
- FFO as Adjusted declined to $0.45 per share from $0.46, highlighting limited underlying earnings growth despite stronger reported net income
Item 5.07: Submission of Matters to a Vote of Security Holders
- Annual meeting achieved quorum with 632,249,628 shares represented, approximately 91% of eligible shares
- All nine director nominees elected, receiving 96.4%–99.8% support; Board size reduced to nine members
AI summaries of DOC 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for DOC
Don't miss the next DOC filing
- Alerts as it files. A push when DOC files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut DOC, by share count.
- Ask anything. An AI agent that reads every DOC filing and answers with sources.
DOC alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Brinker Scott M | A | May 29, 2026 | 1,347 | $15.46 |
| Patadia Ankit B. | F | May 29, 2026 | 94 | $19.15 |
| Johnston Shawn G | F | May 29, 2026 | 76 | $19.15 |
| Moses Kelvin O | F | May 29, 2026 | 65 | $19.15 |
| Mabry Adam G | F | May 29, 2026 | 43 | $19.15 |
| Patadia Ankit B. | A | May 29, 2026 | 1,358 | $15.46 |
| Mabry Adam G | A | May 29, 2026 | 625 | $15.46 |
| Johnston Shawn G | A | May 29, 2026 | 1,358 | $15.46 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $527.4M | $568.5M | $604.0M | |
| Net Income | $306.0M | $243.1M | $71.3M | |
| Net Margin | 58.0% | 42.8% | 11.8% | |
| Balance Sheet | ||||
| Total Assets | $15.7B | $19.9B | $20.3B | |
| Equity | $6.4B | $8.4B | $7.5B | |
| ROE | 4.8% | 2.9% | 1.0% | |
| Per Share | ||||
| EPS | $0.56 | $0.36 | $0.10 | |
| Cash Flow | ||||
| Operating CF | $956.2M | $1.1B | $1.3B | |
Source: XBRL data in Healthpeak Properties (DOC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate DOC share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 41 | $8.41B |
| Q1 2026 | 40 | $6.75B |
| Q4 2025 | 37 | $6.39B |
| Q3 2025 | 40 | $7.88B |
| Q2 2025 | 40 | $6.68B |
| Q1 2025 | 38 | $5.86B |
| Q4 2024 | 34 | $4.93B |
| Q3 2024 | 31 | $2.66B |
- Citadel Advisors LLC+5.54M (+2843%)
- Goldman Sachs Group+4.29M (+59%)
- Two Sigma Investments+2.18M (+450%)
- Morgan Stanley+1.88M (+15%)
- FMR LLC (Fidelity)+1.25M (+14%)
- JPMorgan Chase & Co−14.54M (-33%)
- Invesco Ltd−5.66M (-23%)
- State Street Corp−4.49M (-9%)
- Millennium Management−2.62M (-80%)
- BlackRock−2.43M (-3%)
- D.E. Shaw & Co+44.1K
- First Bancorp, Inc /ME/+2.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 301 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
DOC filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
8-K current reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 10-Q | Aug 5, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - | |
| 4 | May 18, 2026 | - | - | |
| SC 13G | May 14, 2026 | - | - | |
| SC 13G | May 13, 2026 | - | - | |
| 4 | May 13, 2026 | - | - | |
| 4 | May 7, 2026 | - | - | |
| 4 | May 7, 2026 | - | - | |
| 4 | May 7, 2026 | - | - | |
| 4 | May 7, 2026 | - | - | |
| 4 | May 7, 2026 | - | - | |
| 4 | May 7, 2026 | - | - | |
| 4 | May 7, 2026 | - | - | |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 5, 2026 | - | Analysis | - |
| 8-K | May 4, 2026 | - | Analysis | - |
| SC 13G | Apr 30, 2026 | - | - | |
| SC 13G | Apr 29, 2026 | - | - | |
| 8-K | Mar 23, 2026 | - | - | - |
Related Real Estate companies
- AKR · ACADIA REALTY TRUSTReal Estate Investment Trusts
- ACR · ACRES Commercial Realty Corp.Real Estate Investment Trusts
- ADAM · ADAMAS TRUST, INC.Real Estate Investment Trusts
- ALX · ALEXANDERS INCReal Estate Investment Trusts
- ARE · Alexandria Real Estate EquitiesReal Estate Investment Trusts
- PINE · Alpine Income Property Trust, Inc.Real Estate Investment Trusts
- AAT · American Assets Trust, Inc.Real Estate Investment Trusts
- AHR · American Healthcare REIT, Inc.Real Estate Investment Trusts
DOC SEC filings: frequently asked questions
Which institutions hold DOC stock?
As of June 30, 2026, the largest Healthpeak Properties (DOC) holders among the 13F filers tracked by SignalX were BlackRock ($1.5 billion), Vanguard Portfolio Management LLC ($1.2 billion), Vanguard Capital Management LLC ($963.3 million), State Street Corp ($941.8 million), JPMorgan Chase & Co ($661.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was DOC's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Healthpeak Properties (DOC) reported revenue of $604.0 million (up 6.2% from FY2024) and net income of $71.3 million. Diluted EPS was $0.10. The figures come from the XBRL data in the 10-K.
What are the main risks in DOC's latest 10-K?
In the 10-K filed February 3, 2026, Healthpeak Properties (DOC) flagged: U.S. federal policy shifts (NIH funding cuts, drug pricing, tariffs) creating life science tenant funding uncertainty, risking rent payment and expansion. Exposure to Medicare/Medicaid funding cuts and Affordable Care Act subsidy expiration impacting tenants in non-expansion states, affecting outpatient medical segment revenues. (AI summary of the Risk Factors section.)
What did DOC report in its latest 8-K?
Healthpeak Properties (DOC) filed an 8-K on August 4, 2026 reporting Item 7.01 (Regulation FD Disclosure) and Item 2.02 (Results of Operations and Financial Condition). Supplemental report covers Healthpeak’s three and six months ended June 30, 2026.
What are the latest DOC SEC filings?
Healthpeak Properties (DOC) filed its latest 10-K annual report on February 3, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on August 4, 2026 and a Form 4 insider filing on June 2, 2026.
What is DOC's SEC CIK number?
Healthpeak Properties (DOC)'s SEC Central Index Key (CIK) is 765880. EDGAR lists every DOC filing under that number.
Ask anything about DOC
The research agent reads DOC's filings, financials, insider trades and 13F holders, then answers with sources.